Schroder Investment Management Group Eye Point Pharmaceuticals, Inc. Transaction History
Schroder Investment Management Group
- $122 Billion
- Q3 2025
A detailed history of Schroder Investment Management Group transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 247,754 shares of EYPT stock, worth $2.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247,754
Previous 313,979
21.09%
Holding current value
$2.94 Million
Previous $2.95 Million
16.05%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...